Cargando…
3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia
Sphingolipids and their metabolic pathways have been implicated in disease development and therapeutic response; however, the detailed mechanisms remain unclear. Using a sphingolipid network focused CRISPR/Cas9 library screen, we identified an endoplasmic reticulum (ER) enzyme, 3-Ketodihydrosphingos...
Autores principales: | Liu, Qiao, Chan, Anthony K.N., Chang, Wen-Han, Yang, Lu, Pokharel, Sheela Pangeni, Miyashita, Kazuya, Mattson, Nicole, Xu, Xiaobao, Li, Mingli, Lu, Wei, Lin, Ren-Jang, Wang, Shao-Yuan, Chen, Chun-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732298/ https://www.ncbi.nlm.nih.gov/pubmed/34373586 http://dx.doi.org/10.1038/s41375-021-01378-z |
Ejemplares similares
-
3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish
por: Park, Ki-Hoon, et al.
Publicado: (2019) -
Author Correction: 3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish
por: Park, Ki-Hoon, et al.
Publicado: (2020) -
Progressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation
por: Altawil, Lama, et al.
Publicado: (2021) -
ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner
por: Xu, Xiaobao, et al.
Publicado: (2022) -
Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications
por: Kumar, Anil, et al.
Publicado: (2021)